Associated Banc-Corp’s NeoGenomics NEO Stock Holding History

Associated Banc-Corp’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-45	Closed	-$2K	–	658
2020 Q4	$2K	Hold	45	–	–	﹤0.01%	808
2020 Q3	$2K	Hold	45	–	–	﹤0.01%	713
2020 Q2	$1K	Buy	+45	New	+$1.25K	﹤0.01%	876

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Associated Banc-Corp's NEO Position: Q1 2021 in Review

Associated Banc-Corp sold out of NeoGenomics (NEO) in Q1 2021, closing a stake of 45 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in NEO in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q4 2020. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.

Associated Banc-Corp reported no remaining NeoGenomics position as of Q1 2021 after selling out during the quarter.
Associated Banc-Corp sold 45 NeoGenomics shares in Q1 2021, an estimated $2K.
Associated Banc-Corp first reported a position in NeoGenomics in Q2 2020 and held it in 3 quarters.
Associated Banc-Corp's NeoGenomics position peaked at $2K in Q4 2020.
332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.